Background: The risk of venous thromboembolism (VTE) is increased after a myocardial infarction (MI). Some prothrombotic genotypes associated with VTE have also been associated with risk of MI. Whether prothrombotic single-nucleotide polymorphisms (SNPs) further increase the risk of VTE in MI patients is scarcely investigated.
Aim: To study the combined effect of MI and prothrombotic SNPs on the risk of VTE.
Methods: Cases with incident VTE (n = 641) and a randomly sampled subcohort weighted for age (n = 1761) were identified from the 4 to 6 surveys of the Tromsø Study (1994-2012). DNA was genotyped for rs8176719 (), rs6025 (), rs1799963 (), rs2066865 (), and rs2036914 (). Hazard ratios (HRs) for VTE with 95% confidence intervals (CIs) were estimated by categories of risk alleles and MI status.
Results: Patients with MI had a 1.4-fold increased risk of VTE, and adjustments for the 5 SNPs, either alone or in combination, did not affect this relationship (adjusted HR, 1.52; 95% CI, 1.12-2.07). In subjects without MI, an increased risk of VTE was observed for each of the individual SNPs (≥1 vs. 0 risk alleles), and the risk increased linearly with increasing number of risk alleles in the 5-SNP score. The combination of MI and prothrombotic genotypes, either as individual SNPs or in the 5-SNP score, did not result in an excess risk of VTE.
Conclusion: The relationship between MI and VTE was not explained by these 5 prothrombotic genotypes. Prothrombotic genotypes did not yield an excess risk of VTE in patients with MI.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040547 | PMC |
| http://dx.doi.org/10.1002/rth2.12306 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Joint effects of atrial fibrillation and prothrombotic genotypes on the risk of ischemic stroke.
J Thromb Haemost
December 2024
Thrombosis Research Group, Department of Clinical Medicine, UiT The Arctic University of North Norway, Tromsø, Norway; Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway.
Background: Atrial fibrillation (AF) is a major risk factor for ischemic stroke. Whether prothrombotic single nucleotide polymorphisms (SNPs) impact stroke risk in AF is not well known.
Objectives: To investigate the joint effects of 5 prothrombotic SNPs and AF on ischemic stroke risk.
Loss of endogenous Nox2-NADPH oxidase does not prevent age-induced platelet activation and arterial thrombosis in mice.
Res Pract Thromb Haemost
October 2024
Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.
Background: Reactive oxygen species are known to contribute to platelet hyperactivation and thrombosis during aging; however, the mechanistic contribution of the specific oxidative pathway remains elusive.
Objectives: We hypothesized that during aging, endogenous Nox2-NADPH oxidase contributes to platelet reactive oxygen species accumulation and that loss of Nox2 will protect from platelet activation and thrombosis.
Methods: We studied littermates of Nox2 knockout (Nox2-KO) and -wild-type (Nox2-WT) mice at young (3-4 months) and old (18-20 months) age.
Genetic predisposition to vaccine-induced immune thrombotic thrombocytopenia.
Br J Haematol
January 2025
Michael G. DeGroote Centre for Transfusion Research, McMaster University, Hamilton, Ontario, Canada.
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare prothrombotic disorder with a unique clonality-restricted immunological profile. The study by Petito and Bury et al. provides insight into the role of HLA polymorphisms and an inherent predisposition to VITT.
View Article and Find Full Text PDFCan prothrombotic gene variants and Apoa1 rs5069 polymorphism be the predictors of early myocardial infarctions?
Turk J Med Sci
September 2024
Department of Medical Genetics, Faculty of Medicine, Eskişehir Osmangazi University, Eskişehir, Turkiye.
Background/aim: We aimed to determine the genetic risk factors in patients aged 45 years and below with a history of early myocardial infarction (MI), compared to individuals over 60 years of age with no history of MI.
Materials And Methods: In this study, we selected different age groups to more clearly distinguish genetic differences. Accordingly, we compared individuals who had experienced MI at an early age with those who were older and had not experienced any cardiovascular events.
Cerebral venous sinus thrombosis and SCN1A, a novel association?
Mol Biol Rep
August 2024
Division of Genetics, Department of Pediatrics, West Virginia University Medicine, One Medical Center Drive, Morgantown, WV, 26506, USA.
Article Synopsis
- Cerebral venous sinus thrombosis (CVST) is a rare type of stroke primarily linked to genetic and acquired factors that increase the risk of blood clots.
- A study of an adolescent patient with CVST found high levels of homocysteine due to a specific genetic mutation in the MTHFR gene, while his unaffected brother showed similar genetic traits but no symptoms.
- Despite the connection between high homocysteine and CVST through MTHFR polymorphisms, the study suggests that other factors, like abnormalities in blood flow linked to the SCN1A gene, may also play a crucial role in developing thrombosis.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!